# Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy

> **NCT00468871** · PHASE2,PHASE3 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 140 (actual)

## Conditions studied

- Non-infectious Uveitis

## Interventions

- **DRUG:** fluocinolone acetonide intravitreal implant
- **DRUG:** corticosteroids and immunosuppressants

## Key facts

- **NCT ID:** NCT00468871
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2011-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00468871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00468871, "Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00468871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*